0000899243-18-020972.txt : 20180801 0000899243-18-020972.hdr.sgml : 20180801 20180801161704 ACCESSION NUMBER: 0000899243-18-020972 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMullin David CENTRAL INDEX KEY: 0001738662 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36332 FILM NUMBER: 18984973 MAIL ADDRESS: STREET 1: C/O ALDEYRA THERAPEUTICS, INC. STREET 2: 131 HARTWELL AVENUE, SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-761-4904 MAIL ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Aldexa Therapeutics, Inc. DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-07-30 0 0001341235 Aldeyra Therapeutics, Inc. ALDX 0001738662 McMullin David C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON MA 02421 0 1 0 0 SVP Corp. Dev. & Strategy Employee Stock Option (Right to Buy) 7.85 2028-04-30 Common Stock 225000 D This option vests over four (4) years of service following May 1, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter. /s/ David McMullin 2018-08-01